EuropaBio

Publications in OpenAlex of which a co-author is affiliated to this organization

All publications | By field | By subfield

All publications [Next]
Title DOI
https://doi.org/10.1016/j.bioeco.2023.100061 Safety aspects of microorganisms deliberately released into the environment
https://doi.org/10.1007/s00003-007-0244-1 General Surveillance: Roles and Responsibilities The Industry View
https://doi.org/10.1007/s00003-009-0359-7 General Surveillance for Import and Processing: the EuropaBio approach
https://doi.org/10.1016/j.nbt.2017.05.010 Destination bioeconomy – The path towards a smarter, more sustainable future
https://doi.org/10.1021/acs.jafc.5b05116 Global Adoption of Genetically Modified (GM) Crops: Challenges for the Public Sector
https://doi.org/10.4161/gmcr.26776 The use and value of polling to determine public opinion on GMOs in Europe
https://doi.org/10.1016/j.yrtph.2016.03.021 Physicians prefer greater detail in the biosimilar label (SmPC) – Results of a survey across seven European countries
https://doi.org/10.1016/j.foodcont.2022.109170 Recombinant DNA in fermentation products is of no regulatory relevance
https://doi.org/10.1039/c4em00093e The use of existing environmental networks for the post-market monitoring of GM crop cultivation in the EU
https://doi.org/10.2217/17460751.2.1.5 European Approval System for Advanced Therapies: Good News for Patients and Innovators Alike
https://doi.org/10.1089/ind.2014.1537 Industrial Biotechnology in the European Union: Identifying the Best Pathways to Boost Growth of the Bioeconomy
https://doi.org/10.1007/s00003-006-0068-4 Implementation of General Surveillance in Europe: the Industry Perspective
https://doi.org/10.1038/nbt.3515 Community crystal gazing
https://doi.org/10.1089/ind.2012.1503 2012: Make or Break Year for a Leading EU Bioeconomy
https://doi.org/10.1016/s0140-6736(10)61185-3 Clinical Trials Directive: better regulation required now
https://doi.org/10.1038/sj.embor.7400485 Confusion over Article 8
https://doi.org/10.1038/6076 Core ethical values for European bioindustries
https://doi.org/10.20944/preprints202205.0251.v1 Recombinant DNA in Fermentation Products is of No Regulatory Relevance
https://doi.org/10.1002/9783527619511.oth3 Synthesis and Recommendations
https://doi.org/10.1038/13588 Partnerships between patients, medicine, and the biotechnology industry
https://doi.org/10.1038/nbt0108-27b We speak for small biotech
https://doi.org/10.1002/cssc.200800114 SusChem Industrial Biotechnology—Potentials and Challenges in Industrial Biotech in Europe
https://doi.org/10.1016/j.jbiotec.2010.09.921 Towards a bio-based economy in 2020
https://doi.org/10.1016/j.foodchem.2020.128703 RE: Letter to the Editor – Analytical strategy for EU control laboratories to detect the presence of rDNA
https://doi.org/10.32388/57gbaq Review of: "The Plight of Rare Diseases in Southern Africa: Health and Social Services Policy Recommendations"